Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Accumulated Depreciation & Amortization: 2011-2021

  • Avadel Pharmaceuticals' Accumulated Depreciation & Amortization fell 84.96% to $163,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $8.9 million, marking a year-over-year decrease of 43.88%. This contributed to the annual value of $588,000 for FY2023, which is 50.38% up from last year.
  • As of Q4 2021, Avadel Pharmaceuticals' Accumulated Depreciation & Amortization stood at $163,000, which was down 84.96% from $1.1 million recorded in Q4 2020.
  • Avadel Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $7.1 million for Q4 2017, and its period low was $163,000 during Q4 2021.
  • Its 3-year average for Accumulated Depreciation & Amortization is $653,667, with a median of $714,000 in 2019.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 89.73% in 2019, and later skyrocketed by 51.82% in 2020.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Accumulated Depreciation & Amortization stood at $7.1 million in 2017, then dropped by 2.54% to $7.0 million in 2018, then crashed by 89.73% to $714,000 in 2019, then soared by 51.82% to $1.1 million in 2020, then crashed by 84.96% to $163,000 in 2021.
  • Its Accumulated Depreciation & Amortization stands at $163,000 for Q4 2021, versus $1.1 million for Q4 2020 and $714,000 for Q4 2019.